Feasibility and safety of cellular therapy for in-utero repair of myelomeningocele (CuRe Trial): a first-in-human, phase 1, single-arm study. (linkinghub.elsevier.com)

Authors: Farmer DL … Wang A Journal: The Lancet Published: 2026-02-28 DOI: https://doi.org/10.1016/S0140-6736(25)02466-3